FAQ/Help |
Calendar |
Search |
Today's Posts |
03-20-2015, 10:05 AM | #1 | ||
|
|||
Member
|
Prothena rockets up with early data on a Roche-partnered Parkinson's drug
http://www.fiercebiotech.com/story/r...rug/2015-03-19 |
||
Reply With Quote |
03-20-2015, 10:19 AM | #2 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
"Thanks for this!" says: | zanpar321 (03-20-2015) |
03-20-2015, 10:22 AM | #3 | ||
|
|||
Member
|
Quote:
http://www.prothena.com/pipeline/prx...nsons-disease/ The biotech didn't disclose detailed efficacy results from the study but said PRX002 slashed mean alpha-synuclein by as much as 96% after a single dose, a free-of-context data point the company believes bodes well for its ongoing Phase I study on patients with Parkinson's. http://www.fiercebiotech.com/story/r...rug/2015-03-19 |
||
Reply With Quote |
03-20-2015, 10:44 AM | #4 | ||
|
|||
Member
|
|
||
Reply With Quote |
03-20-2015, 10:53 AM | #5 | ||
|
|||
Member
|
|
||
Reply With Quote |
03-20-2015, 10:55 AM | #6 | ||
|
|||
Member
|
|
||
Reply With Quote |
03-20-2015, 02:02 PM | #7 | ||
|
|||
Junior Member
|
|
||
Reply With Quote |
03-20-2015, 05:44 PM | #8 | ||
|
|||
Member
|
Okay lets compare notes.
Last edited by badboy99; 03-20-2015 at 06:20 PM. |
||
Reply With Quote |
03-21-2015, 09:04 PM | #9 | ||
|
|||
Junior Member
|
|
||
Reply With Quote |
03-24-2015, 06:29 PM | #10 | ||
|
|||
Junior Member
|
Family History knocked me out. Guys in Orlando seemed really anxious to get some people in the study. If you are interested sign up on their website they will call you back. Sounded like about a dozen visits over 6-7 months. Two treatments over that time period. Orlando is an easy place to fly in-out of from pretty much anywhere
|
||
Reply With Quote |
"Thanks for this!" says: | Betsy859 (03-25-2015) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Roche to Award $30M Milestone for Prothena's Parkinson's Drug | Parkinson's Disease |